RBM-007 in Subjects witH ExudatIve Age-related Macular Degeneration

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 29, 2018

Primary Completion Date

June 26, 2019

Study Completion Date

June 26, 2019

Conditions

Age-related Macular Degeneration

Interventions

DRUG

RBM-007 Injectable Solution

(No additional description)

Trial Locations (4)

Stanford University, Stanford

Bay Area Retina Associates, Walnut Creek

Retinal Consultants Medical Group, Sacramento

Retinal Consultants Medical Group, Sacramento

All Listed Sponsors

lead

Ribomic USA Inc

INDUSTRY

NCT03633084 - RBM-007 in Subjects witH ExudatIve Age-related Macular Degeneration | Biotech Hunter | Biotech Hunter